Aragen
CRDMO
Aragen is a fully integrated, technology-led CRDMO supporting discovery, development and manufacturing for small molecules and biologics.
Is Aragen hiring?
Yes. As of October 3, 2026, Aragen has 3 open roles on Metaintro.
Open roles
Newest first. Pay shown when the posting lists it.
Customers
All 6 companies Aragen names as customers.
Customers hiring now1
- Avid Bioservices83 open roles
Other customers5
- Serum Institute of India Pvt. Ltd. (SIIPL)
- University of Technology Sydney (UTS)
- Oragenics Inc.
- Goldman Sachs Asset Management
- FMC Corporation
What their customers say
Quotes from people at Aragen's customers.
“SIIPL is very pleased to join hands with Aragen. SIIPL is already in collaboration with IAVI and Scripps Research for the discovery of novel monoclonal antibodies against HIV. With our manufacturing capabilities and this collaboration with Aragen to develop stable cell lines, SIIPL will be able to provide cost-effective monoclonal antibodies against HIV for the developing and developed world.”
“UTS welcomes the strategic partnership with Aragen to provide comprehensive but affordable cell line and expression technology solutions to Australian research communities and start-ups, to tackle the critical bottleneck during pre- and early-clinical stages of biologics development.”
“With pharmaceutical and biotechnology companies focused on delivering their innovative medicines to patients as quickly as possible, this alliance aims to speed the entire cGMP manufacturing process by having a single, integrated team oversee a single, integrated project timeline with significant built-in process efficiencies. We view this collaboration with Aragen as a significant win for current and future clients of both companies and we are excited to contribute our deep CDMO expertise to the partnership, particularly our more than 15 years of commercial product manufacturing experience.”
“Developing a variety of vaccine alternatives is critical to bringing the SARS-Cov-2 pandemic under control. Utilizing the technology created at NIH with Aragen’s pre-clinical development capabilities will help us accelerate the development of the TerraCov2 vaccine candidate. We believe the relationship between the companies will result in advancement of the vaccine candidate into the clinic as rapidly as possible,”
“Aragen is well positioned to benefit from the secular trend of increased outsourcing by the life sciences industry. With a clear value creation plan in place, we look forward to closely working with the management and shareholders of Aragen. Goldman Sachs is actively seeking to invest and foster leading, national champions of India who are building companies of a global scale.”
Show 1 more quoteShow fewer
“Aragen has been a valued collaborator of FMC for several years. This partnership extends across multiple disciplines in research and development and we appreciate our strong working relationship.”
Skills they ask for
Most frequent across open postings.
Tech stack
- Libraries
- Bootstrap
- jQuery
- Marketing
- HubSpot
- Analytics
- Google Tag Manager
- Google Analytics 4
- CMS
- HubSpot CMS
- WordPress
Company facts
- Headquarters
- Hyderabad, India
- Industry
- CRDMO
- Sector (NAICS)
- Professional, Scientific, and Technical Services
- Website
- aragen.com
- Careers
- aragen.com/careers
Questions about Aragen
- Is Aragen hiring?
- Yes. As of October 3, 2026, Aragen has 3 open roles on Metaintro. The most are in Biotechnology and Pharmaceuticals (3).
- Who are Aragen's customers?
- Aragen names 6 customers, including Avid Bioservices, Serum Institute of India Pvt. Ltd. (SIIPL), University of Technology Sydney (UTS), Oragenics Inc., and Goldman Sachs Asset Management.